YTHDF1 and hepatocellular carcinoma: YTHDF1 (m6A “reader”) can be used to predict poor prognosis in breast cancer and promotes FDZ5 translation, leading to hepatocellular carcinoma progression (Anita et al., 2020; Liu X. et al., 2020).